Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species

Journal of Clinical Microbiology

Volumn 49, Issue 2, 2011, Pages 549-556

  Jensen, Rasmus H ^a   Arendrup, Maiken C ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; ESCULIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA FAMATA; CANDIDA FERMENTATI; CANDIDA INTERMEDIA; CANDIDA PALMIOLEOPHILA; CLAVISPORA LUSITANIAE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PICHIA GUILLIERMONDII; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOLOGICAL TYPING TECHNIQUES; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CANDIDA PALMIOLEOPHILA;

EID: 79951481129     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02071-10     Document Type: Article

References (49)

1. Alcoba-Florez, J., et al. 2005. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J. Clin. Microbiol. 43:4107-4111.
2. Arendrup, M. C., et al. National surveillance of fungemia in Denmark (2004 to 2009). J. Clin. Microbiol. 49:325-334.
3. Arendrup, M. C., et al. 2009. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob. Agents Chemother. 53:1185-1193.
4. Arendrup, M. C., et al. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and Iso-Sensitest media. Antimicrob. Agents Chemother. 54:426-439.
5. Atkinson, B. J., R. E. Lewis, and D. P. Kontoyiannis. 2008. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med. Mycol. 46:541-546.
6. Bai, F. Y., H. Y. Liang, and J. H. Jia. 2000. Taxonomic relationships among the taxa in the Candida guilliermondii complex, as revealed by comparative electrophoretic karyotyping. Int. J. Syst. Evol. Microbiol. 50:417-422.
7. Bishop, J. A., et al. 2008. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection. J. Clin. Microbiol. 46:443-446.
8. Borman, A. M., et al. 2008. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J. Clin. Microbiol. 46:933-938.
9. Brillowska-Dabrowska, A. December 2006. DNA preparation from nail samples. Denmark patent WO2006133701.
10. Brillowska-Dabrowska, A., D. M. Saunte, and M. C. Arendrup. 2007. Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum. J. Clin. Microbiol. 45:1200-1204.
11. Coignard, C., et al. 2004. Resolution of discrepant results for Candida species identification by using DNA probes. J. Clin. Microbiol. 42:858-861.
12. Correia, A., P. Sampaio, S. James, and C. Pais. 2006. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int. J. Syst. Evol. Microbiol. 56:313-317.
13. Cuenca-Estrella, M., et al. 2003. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin. Microbiol. Infect. 9:467-474.
14. Desnos-Ollivier, M., et al. 2008. Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii). J. Clin. Microbiol. 46:3237-3242.
15. Fujita, S., and T. Hashimoto. 2000. DNA fingerprinting patterns of Candida species using HinfI endonuclease. Int. J. Syst. Evol. Microbiol. 50:1381-1389.
16. Garey, K. W., et al. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31.
17. Lan, L., and J. Xu. 2006. Multiple gene genealogical analyses suggest divergence and recent clonal dispersal in the opportunistic human pathogen Candida guilliermondii. Microbiology 152:1539-1549.
18. Lockhart, S. R., et al. 2009. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J. Clin. Microbiol. 47:1216-1217.
19. Lockhart, S. R., S. A. Messer, M. A. Pfaller, and D. J. Diekema. 2008. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J. Clin. Microbiol. 46:2659-2664.
20. Lockhart, S. R., S. A. Messer, M. A. Pfaller, and D. J. Diekema. 2008. Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections. J. Clin. Microbiol. 46:374-376.
21. Lockhart, S. R., S. A. Messer, M. A. Pfaller, and D. J. Diekema. 2009. Identification and susceptibility profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. J. Clin. Microbiol. 47:242-244.
22. Marklein, G., et al. 2009. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917.
23. McMullan, R., et al. 2008. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin. Infect. Dis. 46:890-896.
24. Mirhendi, H., et al. 2010. Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. J. Med. Microbiol. 59:414-420.
25. Nakase, T., M. Itoh, M. Suzuki, K. Komagata, and T. Kodama. 1988. Candida palmioleophila sp. nov., a yeast capable of assimilating crude palm oil, formerly identified as Torulopsis candida. J. Gen. Appl. Microbiol. 34:493-498.
26. Nishikawa, A., T. Sugita, and T. Shinoda. 1997. Differentiation between Debaryomyces hansenii/Candida famata complex and Candida guilliermondii by polymerase chain reaction. FEMS Immunol. Med. Microbiol. 19:125-129.
27. Nishikawa, A., T. Sugita, and T. Shinoda. 1999. Rapid identification of Debaryomyces hansenii/Candida famata by polymerase chain reaction. Med. Mycol. 37:101-104.
28. Page, B. T., and C. P. Kurtzman. 2005. Rapid identification of Candida species and other clinically important yeast species by flow cytometry. J. Clin. Microbiol. 43:4507-4514.
29. Page, B. T., C. E. Shields, W. G. Merz, and C. P. Kurtzman. 2006. Rapid identification of ascomycetous yeasts from clinical specimens by a molecular method based on flow cytometry and comparison with identifications from phenotypic assays. J. Clin. Microbiol. 44:3167-3171.
30. Pfaller, M. A., et al. 2010. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J. Clin. Microbiol. 48:52-56.
31. Pfaller, M. A., et al. 2005. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J. Clin. Microbiol. 43:5425-5427.
32. Pfaller, M. A., et al. 2010. Results from the Artemis Disk Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J. Clin. Microbiol. 48:1366-1377.
33. Qian, J., J. E. Cutler, R. B. Cole, and Y. Cai. 2008. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal. Bioanal. Chem. 392:439-449.
34. Romeo, O., F. Scordino, I. Pernice, P. C. Lo, and G. Criseo. 2009. A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis. J. Microbiol. Methods 79:117-120.
35. Rowen, J. L., J. M. Tate, N. Nordoff, L. Passarell, and M. R. McGinnis. 1999. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J. Clin. Microbiol. 37:3735-3737.
36. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
37. San Millan, R. M., L. C. Wu, I. F. Salkin, and P. F. Lehmann. 1997. Clinical isolates of Candida guilliermondii include Candida fermentati. Int. J. Syst. Bacteriol. 47:385-393.
38. Stevenson, L. G., S. K. Drake, Y. R. Shea, A. M. Zelazny, and P. R. Murray. 2010. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) for the identification of clinically important yeast species. J. Clin. Microbiol. 48:3482-3486.
39. Sugita, T., et al. 1999. A clinical isolate of Candida palmioleophila formerly identified as Torulopsis candida. Nippon Ishinkin Gakkai Zasshi 40:21-25.
40. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
41. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521.
42. Szabo, Z., et al. 2008. Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification. J. Clin. Microbiol. 46:1824-1825.
43. Tavanti, A., A. D. Davidson, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
44. Tsui, C. K., H. M. Daniel, V. Robert, and W. Meyer. 2008. Re-examining the phylogeny of clinically relevant Candida species and allied genera based on multigene analyses. FEMS Yeast Res. 8:651-659. (Pubitemid 351678644)
45. van Veen, S. Q., E. C. Claas, and E. J. Kuijper. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization- time of flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48:900-907.
46. Vaughan-Martini, A., C. P. Kurtzman, S. A. Meyer, and E. B. O'Neill. 2005. Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov. FEMS Yeast Res. 5:463-469.
47. Verweij, P. E., I. M. Breuker, A. J. Rijs, and J. F. Meis. 1999. Comparative study of seven commercial yeast identification systems. J. Clin. Pathol. 52:271-273.
48. White, T. J., T. Bruns, S. Lee, and J. Taylor. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322. In M. A. Innis, D. H. Gelfand, and J. J. Sninsky (ed.), PCR protocols. A guide to methods and applications. Academic Press, San Diego, CA.
49. Yamamura, M., et al. 2009. Polymerase chain reaction assay for specific identification of Candida guilliermondii (Pichia guilliermondii). J. Infect. Chemother. 15:214-218.